Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012

Vaccine

Volumn 32, Issue 47, 2014, Pages 6312-6318

  Levy, Avram ^a   Sullivan, Sheena G ^b,c   Tempone, Simone S ^a   Wong, Kerry L M ^b,c   Regan, Annette K ^d   Dowse, Gary K ^d   Effler, Paul V ^d   Smith, David W ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

Author keywords

Data pooling; Influenza; Influenza season; Influenza vaccine; Influenza like illness; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; SEASONAL VARIATION; VERY ELDERLY; VIRUS DETECTION; CASE CONTROL STUDY; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RISK; SENTINEL SURVEILLANCE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; SENTINEL SURVEILLANCE; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84907993226     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.066     Document Type: Article

References (31)

1. World Health Organization WHO Recommendations on the Composition of Influenza Virus Vaccines Geneva 2014, World Health Organization, Available from: 〈http://www.who.int/influenza/vaccines/virus/recommendations/en/〉 [cited 2014 26 Jun].
2. Kissling E., Valenciano M., Cohen J.M., et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One 2011, 6(11):e27622. (PubMed PMID: 22110695. Epub 2011/11/24).
3. Skowronski D.M., Janjua N.Z., De Serres G., et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clin Infect Dis 2012, 55(Apr (3)):332-342. (PubMed PMID: 22539661. Epub 2012/04/28).
4. Kissling E., Valenciano M., Larrauri A., et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013, 18(5). (pii=20390. PubMed PMID: 23399425).
5. Component-specific estimates of 2011-12 influenza vaccine effectiveness based on the Canadian sentinel surveillance system. 10th Canadian Immunization Conference 2012, N. Janjua, D.M. Skowronski, G. De Serres, A. Winter, J.A. Dickinson, M.M. Salaheddin (Eds.).
6. Australian Bureau of Statistics 1306.5-Western Australia at a Glance, 2013 2013, Australian Bureau of Statistics, Canberra, Available from: 〈http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/1306.5main+features22013〉 [cited 2013 30 Aug].
7. Australian Government Department of Health and Ageing Immunise Australia Program 2012 2012, Australian Government Department of Health and Ageing, Available from: 〈http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-influenza〉.
8. Chidlow G., Harnett G., Williams S., et al. Duplex real-time reverse transcriptase PCR assays for rapid detection and identification of pandemic (H1N1) 2009 and seasonal influenza A/H1, A/H3, and B viruses. J Clin Microbiol 2010, 48(Mar (3)):862-866. (PubMed PMID: 20071557. Pubmed Central PMCID: 2832430. Epub 2010/01/15).
9. Chidlow G.R., Harnett G.B., Shellam G.R., et al. An economical tandem multiplex real-time PCR technique for the detection of a comprehensive range of respiratory pathogens. Viruses 2009, 1(Jun (1)):42-56. (PubMed PMID: 21994537. Pubmed Central PMCID: 3185464. Epub 2009/06/01).
10. Chidlow G.R., Harnett G.B., Speers D.J., et al. Evaluation of real-time reverse transcriptase PCR assays for detection of pandemic influenza A/H1N1 2009 virus. J Clin Microbiol 2011, 49(Sep (9)):3444-3445. (PubMed PMID: 21878586. Pubmed Central PMCID: 3165618. Epub 2011/09/01).
11. Hobson D., Curry R.L., Beare A.S., et al. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972, 70(Dec (4)):767-777. (PubMed PMID: 4509641. Pubmed Central PMCID: 2130285. Epub 1972/12/01).
12. Kelly H., Jacoby P., Dixon G.A., et al. Vaccine effectiveness against laboratory-confirmed Influenza in healthy young children: a case-control study. Pediatr Infect Dis J 2011, 30(Feb (2)):107-111. (PubMed PMID: 21079528. Epub 2010/11/17).
13. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31(17)(Apr (19)):2165-2168. (PubMed PMID: 23499601).
14. Orenstein E.W., De Serres G., Haber M.J., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36(Jun (3)):623-631. (PubMed PMID: 17403908. Epub 2007/04/04).
15. Skowronski D., Gilbert M., Tweed S., et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep 2005, 31:181-191.
16. Chu T. EPIWEEK: Stata module to create epidemiological week and equivalent epidemiological year 2010 2010, Available from: 〈http://ideas.repec.org/c/boc/bocode/s4571521.html〉.
17. StataCorp Stata statistical software: release 12 2011, StataCorp LP, College Station, TX.
18. Fielding J.E., Grant K.A., Garcia K., et al. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011, (Jul (7)):1181-1187. (PubMed PMID: 21762570 Epub 2011/07/19).
19. Fielding J., Grant K., Tran T., et al. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveill 2012, 17(11). (pii=20115. Epub 2012/03/15).
20. Ohmit S.E., Thompson M.G., Petrie J.G. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58(Feb (3)):319-327. (PubMed PMID: 24235265).
21. Pebody R., Andrews N., McMenamin J., et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013, 18(5). (pii=20389, PubMed PMID: 23399424).
22. Castilla J., Martinez-Baz I., Martinez-Artola V., et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013, 18(5). (pii=20388. PubMed PMID: 23399423).
23. Sullivan SG, Komadina N, Grant K, et al. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match J Med Virol. 2014 Jun;86(6):1017-25. PubMed PMID: 24395730.
24. Cowling B.J., Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology 2012, (Nov (6)):930-931. (PubMed PMID: 23038121).
25. Foppa I.M., Haber M., Ferdinands J.M., et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30)(Jun (26)):3104-3109. (PubMed PMID: 23624093).
26. Sundaram M.E., McClure D.L., Vanwormer J.J., et al. Influenza vaccination is not associated with detection of non-influenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis 2013, 57(Sept (6)):789-793. (PubMed PMID: 23748138).
27. Cowling B.J., Fang V.J., Nishiura H., et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis 2012, 54(Jun (12)):1778-1783. (PubMed PMID: 22423139. Pubmed Central PMCID: 3404712. Epub 2012/03/17).
28. De Serres G., Skowronski D.M., Wu X.W., et al. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials Vaccine. Euro Surveill 2013, 18(37). (pii=20585, PubMed PMID: 24079398).
29. Carrat F., Vergu E., Ferguson N.M., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167(Apr (7)):775-785. (PubMed PMID: 18230677. Epub 2008/01/31).
30. Sullivan S.G., Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007-2012. Euro Surveill 2013, 18(Oct (41)). (pii=20605. Epub 10 Oct 2013).
31. Valenciano M., Ciancio B., Moren A. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveill 2008, 13(Oct (43)). (pii=19015, PubMed PMID: 18947520. Epub 2008/10/25).